We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
13.50 | 0.76% | 1,794.00 | 1,793.50 | 1,794.50 | 1,797.50 | 1,780.00 | 1,784.00 | 1,523,654 | 15:11:35 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.97 | 73.8B |
Date | Subject | Author | Discuss |
---|---|---|---|
19/2/2021 17:16 | Correct Stewart. CEO needs to walk, and not get her payoff because she has failed. Abject failure should not be rewarded. She has had plenty of time now. | geckotheglorious | |
19/2/2021 17:12 | Gsk did very well between 18-20 and has had awful 20-21. Way too gloomy imo, shingrix will be firing away again | daneswooddynamo | |
19/2/2021 16:54 | .. maximum pessimism - just how I like it | eurofox | |
19/2/2021 16:50 | And that's the point now, Essential, credibility and trust have gone. We really need a new CEO and a new Chairman. The 'leadership' is the big issue at the moment. GSK might come up with some corker drugs, and they might get the vaccine right with Sanofi, but the leadership has been found wanting. | poikka | |
19/2/2021 16:45 | 65 pence looks highly optimistic!!. Who am I to argue with very highly paid pharma sector analysts and their modelling tbf. | essentialinvestor | |
19/2/2021 16:27 | Why would you split the company. Each part would be worth small change to a competitor - another great British company gets swallowed up. Only wondering - have started following this as it appears oversold charts wise. Don't hold any stock... thankfully! | cw2000 | |
19/2/2021 16:26 | Illiterate | blue59 | |
19/2/2021 16:03 | the only reason this is going down is because there is a large overhang of income-orientated funds selling in expectation of the dividend being cut and the company being split into 2. Always happens prior to a split. | luddenden7 | |
19/2/2021 15:46 | 26% wiped off the price equating to £15B. So that's circa £81,000,000 per week or £11,500,000 per day under her stewardship. That really does take some doing..... spud | spud | |
19/2/2021 15:39 | April fools - How apt! spud | spud | |
19/2/2021 15:34 | Watfordhornet, the price of GSK on April fools' day 2017 ( whence the CEO was appointed)....1659.5 Add back four year's dividend of 320p and it's a loss now over her tenure. | stewart64 | |
19/2/2021 15:32 | GSK, for tuck away, miners looking toppy.. | montyhedge | |
19/2/2021 15:31 | monty...would you buy GSK or Miners?... | diku | |
19/2/2021 15:23 | Astra getting whacked. | montyhedge | |
19/2/2021 15:22 | Brutal day for all the consumer dollar plays. | daneswooddynamo | |
19/2/2021 15:20 | Another brutal day for Glaxo shareholders. Yet again. | devilliers | |
19/2/2021 15:17 | 1150, 1050, 950...EW will still be there grinning like a Cheshire cat cos she's doing a great job on Diversity. Shareholders are just an afterthought. | stewart64 | |
19/2/2021 15:15 | Had emma started an analysts call?! | spoole5 | |
19/2/2021 15:01 | Weak dollar or strong dollar Commodities/Miners just go up... | diku | |
19/2/2021 15:00 | Weak dollar good for commodities.Pound at this level, wonder if back 1.55 eventually. | montyhedge | |
19/2/2021 14:58 | No, I know what it will be on her last day, 1150p | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions